MetLife Broadens Upwise Reach Through Nayya and Workday Deal

24.06.25 18:58 Uhr

Werte in diesem Artikel
Aktien

67,91 EUR -0,75 EUR -1,09%

Indizes

PKT PKT

17.103,3 PKT 168,7 PKT 1,00%

2.979,7 PKT 33,2 PKT 1,13%

6.092,2 PKT 67,0 PKT 1,11%

MetLife, Inc. MET recently announced that it is broadening the reach of Upwise—its benefits experience platform— through a strategic partnership with Nayya. The platform is now offered to employers via the Workday Marketplace as a result of the expansion. Starting Oct. 1, 2025, Upwise will be available at no additional cost to employers through the Workday Marketplace. This offering is targeted at employers who either currently have or choose to include MetLife’s Accident, Hospital Indemnity or Critical Illness insurance products as part of their benefits packages. It will be accessible to Workday Human Capital Management and Workday Benefits customers.This move marks a pivotal step in MetLife’s strategy to reinforce its market leadership and tackle the widespread benefits 'confusion gap’ affecting today’s workforce. Since its launch in 2024, Upwise has received highly positive feedback, with 64% of employees reporting that it helped simplify their benefits decision-making process.Benefits of the Recent Move to MetLifeThe recent move reflects MetLife’s sincere efforts to bring about a streamlined benefit decision-making process, which may result in a higher degree of customer satisfaction and improved retention rates. The announcement also seems to be in line with the company’s endeavor to upgrade its benefits offerings.As a result of the extensive benefits offered by the Upwise solution, more people may opt for MET’s Employee Benefit plans, which will fetch higher premiums for the insurer. Total premiums of MetLife advanced 16.6% year over year in the first quarter of 2025.MetLife’s Share Price Performance & Zacks RankShares of MetLife have gained 12.5% in the past year compared with the industry’s 10.4% growth. MET currently carries a Zacks Rank #3 (Hold).Image Source: Zacks Investment ResearchStocks to ConsiderSome better-ranked stocks in the insurance space are Horace Mann Educators Corporation HMN, Old Republic International Corporation ORI and Kemper Corporation KMPR. While Horace Mann sports a Zacks Rank #1 (Strong Buy), Old Republic and Kemper carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.Horace Mann’s earnings surpassed estimates in three of the last four quarters and matched the mark once, the average surprise being 24.09%. The Zacks Consensus Estimate for HMN’s 2025 earnings implies an improvement of 26.1% from the year-ago reported figure, while the same for revenues implies growth of 6.6%. The consensus mark for HMN’s 2025 earnings has moved 5.5% north in the past 60 days. The bottom line of Old Republic outpaced earnings estimates in each of the last four quarters, the average surprise being 39.61%. The Zacks Consensus Estimate for ORI’s 2025 earnings implies an improvement of 5.6% from the year-ago reported figure, while the same for revenues implies growth of 7.8%. The consensus mark for ORI’s 2025 earnings has moved 0.6% north in the past 60 days. Kemper’s earnings surpassed estimates in each of the last four quarters, the average surprise being 21.11%. The Zacks Consensus Estimate for KMPR’s 2025 earnings indicates an improvement of 7.6% from the year-ago reported figure, while the same for revenues implies growth of 7.5%. The consensus mark for KMPR’s 2025 earnings has moved 5.1% north in the past 60 days. Shares of Horace Mann, Old Republic and Kemper have gained 32.1%, 23.9% and 11.1%, respectively, in the past year. Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MetLife, Inc. (MET): Free Stock Analysis Report Old Republic International Corporation (ORI): Free Stock Analysis Report Kemper Corporation (KMPR): Free Stock Analysis Report Horace Mann Educators Corporation (HMN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: MetLife und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf MetLife

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf MetLife

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu MetLife Inc.

Wer­bung

Analysen zu MetLife Inc.

DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
DatumRatingAnalyst
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
05.05.2016MetLife OutperformRBC Capital Markets
31.07.2015MetLife BuyDeutsche Bank AG
22.06.2015MetLife OutperformRBC Capital Markets
DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
13.07.2016MetLife HoldDeutsche Bank AG
15.03.2016MetLife NeutralUBS AG
DatumRatingAnalyst
04.12.2006Update MetLife Inc.: UnderperformFriedman, Billings Ramsey & Co
14.09.2005MetLife DowngradeDeutsche Securities
14.09.2005Update MetLife Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MetLife Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen